Also, focused in early mortality after dialysis initiation (3 months), Thamer et al. [37], using the US Renal Data System (patients aged ≥ 67 years), validated a score and proposed a simple risk assessment questionnaire, based on ready available information (age, low albumin, assistance with daily living, nursing home residence, cancer, heart failure, and hospitalization). The gene discussed is ALB; the disease is heart failure.